Deadly waiting game for prostate cancer drugs

Prostate cancer patients have to wait many years to get access to new cancer medicines compared to other countries such as the US. This is resulting in poorer quality of life and death for Australians, according to Australian Advanced Prostate Cancer Support Group committee member Paul Hobson. Hobson cites the example of two new anti-androgen